Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma ; volume:38 ; number:1 ; day:9 ; month:8 ; year:2019 ; pages:1-22 ; date:12.2019
Journal of experimental & clinical cancer research ; 38, Heft 1 (9.8.2019), 1-22, 12.2019
- Urheber
-
Pulito, Claudio
Korita, Etleva
Sacconi, Andrea
Valerio, Mariacristina
Casadei, Luca
Lo Sardo, Federica
Mori, Federica
Ferraiuolo, Maria
Grasso, Giuseppe
Maidecchi, Anna
Lucci, Jacopo
Sudol, Marius
Muti, Paola
Blandino, Giovanni
Strano, Sabrina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-019-1352-3
- URN
-
urn:nbn:de:101:1-2019123000032720914753
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pulito, Claudio
- Korita, Etleva
- Sacconi, Andrea
- Valerio, Mariacristina
- Casadei, Luca
- Lo Sardo, Federica
- Mori, Federica
- Ferraiuolo, Maria
- Grasso, Giuseppe
- Maidecchi, Anna
- Lucci, Jacopo
- Sudol, Marius
- Muti, Paola
- Blandino, Giovanni
- Strano, Sabrina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Molecular downstream mechanisms of the oncogenic transcriptional regulators YAP/TAZ in hepatocarcinogenesis
YAP/TAZ drives Notch and angiogenesis mechanoregulation in silico
Hippo-YAP/TAZ signaling in neural crest development and neuroblastoma
Role of YAP/TAZ in endothelial cell growth and metabolism
DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis
The role of YAP/TAZ activity in cancer metabolic reprogramming
AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis
YAP and TAZ are dispensable for physiological and malignant haematopoiesis
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis
YAP/TAZ interacts with RBM39 to confer resistance against indisulam
Targeting the YAP/TAZ Hippo signaling pathway for oral cancer treatment
Context-dependent roles of YAP/TAZ in stem cell fates and cancer
Molecular downstream mechanisms of the oncogenic transcriptional regulators YAP/TAZ in hepatocarcinogenesis
YAP/TAZ drives Notch and angiogenesis mechanoregulation in silico
Hippo-YAP/TAZ signaling in neural crest development and neuroblastoma
Role of YAP/TAZ in endothelial cell growth and metabolism
DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis
The role of YAP/TAZ activity in cancer metabolic reprogramming
AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis
YAP and TAZ are dispensable for physiological and malignant haematopoiesis
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis
YAP/TAZ interacts with RBM39 to confer resistance against indisulam
Targeting the YAP/TAZ Hippo signaling pathway for oral cancer treatment
Context-dependent roles of YAP/TAZ in stem cell fates and cancer
Molecular downstream mechanisms of the oncogenic transcriptional regulators YAP/TAZ in hepatocarcinogenesis
YAP/TAZ drives Notch and angiogenesis mechanoregulation in silico
Hippo-YAP/TAZ signaling in neural crest development and neuroblastoma
Role of YAP/TAZ in endothelial cell growth and metabolism
DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis
The role of YAP/TAZ activity in cancer metabolic reprogramming
AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis
YAP and TAZ are dispensable for physiological and malignant haematopoiesis
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis
YAP/TAZ interacts with RBM39 to confer resistance against indisulam
Targeting the YAP/TAZ Hippo signaling pathway for oral cancer treatment